What type of study is this?

This is a Systematic Review study.

What question did this study set out to answer?

This research evaluates the prevalence and clinical significance of genomic alterations in brain metastases from lung cancer.

March 15, 2026Neuro-Oncology AdvancesOpen Access

Genomic Drivers of Brain Metastases in Lung Cancer

View Full Paper

Ask AI

Bookmark

This research evaluates the prevalence and clinical significance of genomic alterations in brain metastases from lung cancer.
Systematic review of 19 studies with 3028 patients, 930 with brain metastases.
Data sourced from PubMed, Web of Science, Embase, and the Cochrane Library.
50% of brain metastases patients had TP53 mutations.
49% exhibited PD-L1 overexpression.
30% had tumor mutational burden ≥10 mut/Mb, linked to tumor progression and immune evasion.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Systematic review shows genomic profiling informs precision medicine for brain metastases in lung cancer, highlighting tumor progression and immune evasion.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/69b5ff8d83145bc643d1c57b https://doi.org/10.1093/noajnl/vdag067

View Full Paper

Ask AI

Bookmark

Implication

Systematic review shows genomic profiling informs precision medicine for brain metastases in lung cancer, highlighting tumor progression and immune evasion.

Genomic Drivers of Brain Metastases in Lung Cancer

Key Points

Discussion

Implication

Cite This Study

Genomic Drivers of Brain Metastases in Lung Cancer

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider